BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12036897)

  • 1. Correction of the murine Wiskott-Aldrich syndrome phenotype by hematopoietic stem cell transplantation.
    Strom TS; Li X; Cunningham JM; Nienhuis AW
    Blood; 2002 Jun; 99(12):4626-8. PubMed ID: 12036897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice.
    Klein C; Nguyen D; Liu CH; Mizoguchi A; Bhan AK; Miki H; Takenawa T; Rosen FS; Alt FW; Mulligan RC; Snapper SB
    Blood; 2003 Mar; 101(6):2159-66. PubMed ID: 12433691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful Reduced Intensity Allogeneic Transplant With Full Donor Chimerism and Good Quality of Life in Adolescent Patient With Wiskott-Aldrich Syndrome.
    Ali S; Gacsadi A; McDougall E; Armstrong C; Krueger J; Schechter T; Ali M
    J Pediatr Hematol Oncol; 2017 Jul; 39(5):e267-e269. PubMed ID: 28538502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factor analysis of bloodstream infection in pediatric patients after hematopoietic stem cell transplantation.
    Sarashina T; Yoshida M; Iguchi A; Okubo H; Toriumi N; Suzuki D; Sano H; Kobayashi R
    J Pediatr Hematol Oncol; 2013 Jan; 35(1):76-80. PubMed ID: 22995926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wiskott-Aldrich syndrome.
    Notarangelo LD; Miao CH; Ochs HD
    Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
    Boztug K; Dewey RA; Klein C
    Curr Opin Mol Ther; 2006 Oct; 8(5):390-5. PubMed ID: 17078381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and emerging treatment options for Wiskott-Aldrich syndrome.
    Worth AJ; Thrasher AJ
    Expert Rev Clin Immunol; 2015; 11(9):1015-32. PubMed ID: 26159751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unrelated partially matched peripheral blood stem cell transplantation with highly purified CD34+ cells in a child with Wiskott-Aldrich syndrome.
    Schwinger W; Urban C; Lackner H; Kerbl R; Benesch M; Dornbusch HJ; Sovinz P; Schumm M; Handgretinger R
    Bone Marrow Transplant; 2000 Jul; 26(2):235-7. PubMed ID: 10918439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic peripheral blood stem cell transplantation in a Wiskott-Aldrich syndrome patient.
    Hongeng S; Pakakasama S; Hathirat P; Chaisiripoomkere W; Ungkanont A
    Bone Marrow Transplant; 1999 Aug; 24(4):445-6. PubMed ID: 10467341
    [No Abstract]   [Full Text] [Related]  

  • 10. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice.
    Charrier S; Stockholm D; Seye K; Opolon P; Taveau M; Gross DA; Bucher-Laurent S; Delenda C; Vainchenker W; Danos O; Galy A
    Gene Ther; 2005 Apr; 12(7):597-606. PubMed ID: 15616597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful allogeneic hemopoietic stem cell transplantation in a case of Wiskott-Aldrich syndrome and non-Hodgkin lymphoma.
    Tavil B; Erdem AY; Azik F; Isik P; Metin A; Emir S; Uckan D; Tunc B
    Pediatr Transplant; 2013 Sep; 17(6):E146-8. PubMed ID: 23773507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation.
    Ozsahin H; Cavazzana-Calvo M; Notarangelo LD; Schulz A; Thrasher AJ; Mazzolari E; Slatter MA; Le Deist F; Blanche S; Veys P; Fasth A; Bredius R; Sedlacek P; Wulffraat N; Ortega J; Heilmann C; O'Meara A; Wachowiak J; Kalwak K; Matthes-Martin S; Gungor T; Ikinciogullari A; Landais P; Cant AJ; Friedrich W; Fischer A
    Blood; 2008 Jan; 111(1):439-45. PubMed ID: 17901250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful Reduced Intensity Conditioning Alternate Donor Stem Cell Transplant for Wiskott-Aldrich Syndrome.
    Thakkar D; Katewa S; Rastogi N; Kohli S; Nivargi S; Yadav SP
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):e493-e496. PubMed ID: 28859032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable mixed chimerism after hematopoietic stem cell transplantation in Wiskott-Aldrich syndrome.
    Doğu F; Kurtuluş-Ulküer M; Bilge Y; Bozdoğan G; Ulküer U; Malhatun E; Ikincioğullari A; Babacan E
    Pediatr Transplant; 2006 May; 10(3):395-9. PubMed ID: 16677369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Phenotype and Treatment of WIP Deficiency: Literature Synopsis and Review of a Patient With Pre-transplant Serial Donor Lymphocyte Infusions to Eliminate CMV.
    Schwinger W; Urban C; Ulreich R; Sperl D; Karastaneva A; Strenger V; Lackner H; Boztug K; Albert MH; Benesch M; Seidel MG
    Front Immunol; 2018; 9():2554. PubMed ID: 30450104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune thyroiditis following HLA-matched sibling hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome.
    Knight T; Kotz K; Savaşan S
    Pediatr Transplant; 2018 Aug; 22(5):e13222. PubMed ID: 29761856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous manifestations in patients with Wiskott-Aldrich syndrome submitted to haematopoietic stem cell transplantation.
    Loyola Presa JG; de Carvalho VO; Morrisey LR; Bonfim CM; Abagge KT; Vasselai A; Marinoni LP
    Arch Dis Child; 2013 Apr; 98(4):304-7. PubMed ID: 23343520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
    Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
    Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the biology of Wiskott-Aldrich syndrome (WAS).
    Thrasher AJ
    Hematology Am Soc Hematol Educ Program; 2009; ():132-8. PubMed ID: 20008191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.